Comprehensive Pharmaceutical Supply for Indian Army Facility in Jalandhar

This tender, bid number GEM/2026/B/7938111, issued by the Department of Military Affairs, Ministry of Defence, on behalf of the Indian Army, seeks the supply of a comprehensive range of pharmaceutical products to its facility in Jalandhar City. The procurement, scheduled to commence on October 10, 2026, at 7:00 PM and conclude on October 12, 2026, at 7:00 PM, encompasses a significant quantity of 1,017,536 units. The diverse item category includes, but is not limited to, medications such as Duloxetine, Ethinyl Estradiol with Cyproterone Acetate, Serratiopeptidase with Paracetamol and Diclofenac, Eplerenone, Ethinyl Estradiol with Drospirenone, Fluoxetine HCl, Fluvoxamine, Glucosamine with MSM and Diacerein, Iguratimod, Imipramine, Levosulpride, Lisinopril, Memantine with Donepezil, Ergotamine Tartrate combinations, Pioglitazone Hydrochloride, Pregabalin combinations, Teno-fo-vir Alfenamide, Terazosin, Theophylline SR, Venlafaxine, Chlorthalidone, and Donepezil, as well as Cerebroprotein Hydrolysate and Essential Amino Acids. Interested and qualified bidders are invited to submit their proposals within the specified timeframe.